Register Now
Why register?
 The leading web portal for pharmacy resources, news, education and careers March 23, 2019
Pharmacy Choice - Pharmaceutical News - LUPIN SCHIZOPHRENIA DRUG APPROVED - March 23, 2019

Pharmacy News Article


Pharmaceutical major Lupin Limited has received approval from the US Food and Drug Administration (FDA) to market Lurasidone Hydrochloride tablets, in the American market. This is indicated in the treatment of schizophrenia. Lupin got approval from US health regulator, the to market its product, a generic version of Latuda tablets from Sunovion Pharmaceuticals Inc, in strengths of 20, 40, 60, 80 and 120 milligram.

Copyright (c) 2019 . Informatics India Ltd.

Pharmacy News Index
  Drug Delivery Systems
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry


Last Chance
Mar 24: A Look Inside the Top 200 Drugs
Mar 25: Medication Use During Pregnancy & Lactation
Mar 26: Nutrigenomics - Nutritional Influences on the Genome
Mar 27: ADHD in Children & Adults: Etiology, Pathology, Pharmacotherapy
Mar 28: Alternatives and Complements to Prescription Pain Management
Click for entire Webinar Calendar

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...

Nursing Jobs
Are you a nurse looking for a job?

Check out the Nursing Job Source.

Your number one choice for nursing jobs.

Websites »
Copyright © 2019 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement